nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—Crohn's disease	0.823	1	CbGaD
Amlexanox—IL3—lymphoid tissue—Crohn's disease	0.00509	0.0952	CbGeAlD
Amlexanox—PDE4C—mouth—Crohn's disease	0.00403	0.0754	CbGeAlD
Amlexanox—FGF1—mouth—Crohn's disease	0.00332	0.0621	CbGeAlD
Amlexanox—S100A13—epithelium—Crohn's disease	0.00313	0.0587	CbGeAlD
Amlexanox—S100A12—epithelium—Crohn's disease	0.00309	0.0579	CbGeAlD
Amlexanox—S100A13—smooth muscle tissue—Crohn's disease	0.00302	0.0566	CbGeAlD
Amlexanox—S100A13—skin of body—Crohn's disease	0.00298	0.0558	CbGeAlD
Amlexanox—IL3—lymph node—Crohn's disease	0.00287	0.0537	CbGeAlD
Amlexanox—S100A12—mammalian vulva—Crohn's disease	0.00268	0.0502	CbGeAlD
Amlexanox—S100A13—Methyldopa—Mesalazine—Crohn's disease	0.00242	1	CbGdCrCtD
Amlexanox—S100A13—digestive system—Crohn's disease	0.00238	0.0447	CbGeAlD
Amlexanox—S100A12—lymphoid tissue—Crohn's disease	0.00238	0.0446	CbGeAlD
Amlexanox—S100A12—digestive system—Crohn's disease	0.00235	0.0441	CbGeAlD
Amlexanox—FGF1—epithelium—Crohn's disease	0.00193	0.0361	CbGeAlD
Amlexanox—FGF1—smooth muscle tissue—Crohn's disease	0.00186	0.0348	CbGeAlD
Amlexanox—FGF1—skin of body—Crohn's disease	0.00183	0.0344	CbGeAlD
Amlexanox—FGF1—lymphoid tissue—Crohn's disease	0.00149	0.0278	CbGeAlD
Amlexanox—FGF1—digestive system—Crohn's disease	0.00147	0.0275	CbGeAlD
Amlexanox—S100A13—lymph node—Crohn's disease	0.00136	0.0255	CbGeAlD
Amlexanox—S100A12—lymph node—Crohn's disease	0.00134	0.0252	CbGeAlD
Amlexanox—PDE4B—mammalian vulva—Crohn's disease	0.000944	0.0177	CbGeAlD
Amlexanox—PDE4D—lymph node—Crohn's disease	0.000896	0.0168	CbGeAlD
Amlexanox—FGF1—lymph node—Crohn's disease	0.000838	0.0157	CbGeAlD
Amlexanox—PDE4B—lymphoid tissue—Crohn's disease	0.000838	0.0157	CbGeAlD
Amlexanox—PDE4A—lymph node—Crohn's disease	0.000793	0.0149	CbGeAlD
Amlexanox—PDE4B—lymph node—Crohn's disease	0.000473	0.00886	CbGeAlD
Amlexanox—PDE4C—Signaling by GPCR—IL3—Crohn's disease	5.25e-05	0.000433	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL2RA—Crohn's disease	5.25e-05	0.000433	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—STAT3—Crohn's disease	5.24e-05	0.000432	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SEL1L—Crohn's disease	5.24e-05	0.000432	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—PTGER4—Crohn's disease	5.21e-05	0.00043	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCR9—Crohn's disease	5.17e-05	0.000427	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—SOCS1—Crohn's disease	5.16e-05	0.000426	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RSPO3—Crohn's disease	5.15e-05	0.000425	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—IL6—Crohn's disease	5.13e-05	0.000424	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—STAT3—Crohn's disease	5.12e-05	0.000423	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—UBE2D1—Crohn's disease	5.12e-05	0.000423	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PTGER4—Crohn's disease	5.11e-05	0.000422	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—TYK2—Crohn's disease	5.1e-05	0.000421	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—TYK2—Crohn's disease	5.09e-05	0.00042	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—RASGRP1—Crohn's disease	5.08e-05	0.000419	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GPR65—Crohn's disease	5.05e-05	0.000417	CbGpPWpGaD
Amlexanox—FGF1—Disease—GCKR—Crohn's disease	5.04e-05	0.000416	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NOD1—Crohn's disease	5.04e-05	0.000416	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL3—Crohn's disease	5.03e-05	0.000416	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RIPK2—Crohn's disease	4.97e-05	0.00041	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—SOCS1—Crohn's disease	4.96e-05	0.000409	CbGpPWpGaD
Amlexanox—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	4.95e-05	0.000409	CbGpPWpGaD
Amlexanox—IL3—Immune System—CRP—Crohn's disease	4.95e-05	0.000408	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SEL1L—Crohn's disease	4.88e-05	0.000403	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—RASGRP1—Crohn's disease	4.87e-05	0.000402	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—JAK2—Crohn's disease	4.86e-05	0.000401	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—JAK2—Crohn's disease	4.85e-05	0.000401	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GPR65—Crohn's disease	4.81e-05	0.000397	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL3—Crohn's disease	4.79e-05	0.000396	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCR9—Crohn's disease	4.79e-05	0.000395	CbGpPWpGaD
Amlexanox—IL3—Immune System—TLR4—Crohn's disease	4.74e-05	0.000392	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL18—Crohn's disease	4.74e-05	0.000391	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PTGER4—Crohn's disease	4.73e-05	0.00039	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RASGRP1—Crohn's disease	4.68e-05	0.000387	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	4.64e-05	0.000383	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—RASGRP1—Crohn's disease	4.63e-05	0.000383	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CD4—Crohn's disease	4.6e-05	0.00038	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CCR6—Crohn's disease	4.57e-05	0.000378	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL3—Crohn's disease	4.57e-05	0.000377	CbGpPWpGaD
Amlexanox—IL3—Immune System—ICAM1—Crohn's disease	4.55e-05	0.000375	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCR9—Crohn's disease	4.46e-05	0.000369	CbGpPWpGaD
Amlexanox—FGF1—Disease—SLC11A1—Crohn's disease	4.46e-05	0.000368	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GPR65—Crohn's disease	4.45e-05	0.000367	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL3—Crohn's disease	4.43e-05	0.000366	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—RASGRP1—Crohn's disease	4.42e-05	0.000365	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—IL6—Crohn's disease	4.39e-05	0.000362	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	4.36e-05	0.00036	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL3—Crohn's disease	4.35e-05	0.000359	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—RASGRP1—Crohn's disease	4.29e-05	0.000354	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.27e-05	0.000352	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—JAK2—Crohn's disease	4.25e-05	0.000351	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SOCS1—Crohn's disease	4.24e-05	0.00035	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—RASGRP1—Crohn's disease	4.21e-05	0.000347	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL2RA—Crohn's disease	4.2e-05	0.000347	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—IL6—Crohn's disease	4.2e-05	0.000347	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PTPN2—Crohn's disease	4.18e-05	0.000345	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GPR65—Crohn's disease	4.15e-05	0.000343	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCR6—Crohn's disease	4.14e-05	0.000341	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RBX1—Crohn's disease	4.14e-05	0.000341	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—IL6—Crohn's disease	4.13e-05	0.000341	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL2RA—Crohn's disease	4.05e-05	0.000334	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—TYK2—Crohn's disease	4.05e-05	0.000334	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL3—Crohn's disease	4.03e-05	0.000332	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CRP—Crohn's disease	3.97e-05	0.000327	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—IL6—Crohn's disease	3.95e-05	0.000326	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—IL6—Crohn's disease	3.93e-05	0.000324	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—IL6—Crohn's disease	3.91e-05	0.000323	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—RASGRP1—Crohn's disease	3.89e-05	0.000321	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CRP—Crohn's disease	3.89e-05	0.000321	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—IL6—Crohn's disease	3.89e-05	0.000321	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CXCL8—Crohn's disease	3.88e-05	0.00032	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—JAK2—Crohn's disease	3.86e-05	0.000319	CbGpPWpGaD
Amlexanox—FGF1—Disease—RBX1—Crohn's disease	3.82e-05	0.000315	CbGpPWpGaD
Amlexanox—FGF1—Disease—HSPA1B—Crohn's disease	3.82e-05	0.000315	CbGpPWpGaD
Amlexanox—S100A12—Immune System—TLR4—Crohn's disease	3.8e-05	0.000314	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RBX1—Crohn's disease	3.74e-05	0.000309	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—TLR4—Crohn's disease	3.73e-05	0.000308	CbGpPWpGaD
Amlexanox—IL3—Immune System—TYK2—Crohn's disease	3.7e-05	0.000305	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL2RA—Crohn's disease	3.68e-05	0.000304	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SMAD3—Crohn's disease	3.66e-05	0.000302	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—IL6—Crohn's disease	3.66e-05	0.000302	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	3.66e-05	0.000302	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—IL6—Crohn's disease	3.66e-05	0.000302	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ICAM1—Crohn's disease	3.65e-05	0.000301	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTGER4—Crohn's disease	3.64e-05	0.000301	CbGpPWpGaD
Amlexanox—FGF1—Immune System—UBE2D1—Crohn's disease	3.63e-05	0.000299	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—IL6—Crohn's disease	3.63e-05	0.000299	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCR6—Crohn's disease	3.6e-05	0.000297	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—IL6—Crohn's disease	3.59e-05	0.000297	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—IL6—Crohn's disease	3.58e-05	0.000295	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—STAT3—Crohn's disease	3.57e-05	0.000295	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL2RA—Crohn's disease	3.53e-05	0.000291	CbGpPWpGaD
Amlexanox—IL3—Immune System—JAK2—Crohn's disease	3.53e-05	0.000291	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CXCL8—Crohn's disease	3.52e-05	0.000291	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RIPK2—Crohn's disease	3.52e-05	0.00029	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ITGA4—Crohn's disease	3.52e-05	0.00029	CbGpPWpGaD
Amlexanox—IL3—Immune System—IFNG—Crohn's disease	3.46e-05	0.000286	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ICAM1—Crohn's disease	3.43e-05	0.000284	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL3—Crohn's disease	3.43e-05	0.000283	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCR6—Crohn's disease	3.43e-05	0.000283	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2RA—Crohn's disease	3.39e-05	0.00028	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2RA—Crohn's disease	3.36e-05	0.000277	CbGpPWpGaD
Amlexanox—FGF1—Disease—UBE2D1—Crohn's disease	3.35e-05	0.000276	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD4—Crohn's disease	3.34e-05	0.000276	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RASGRP1—Crohn's disease	3.32e-05	0.000274	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD79A—Crohn's disease	3.31e-05	0.000273	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—UBE2D1—Crohn's disease	3.28e-05	0.000271	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RBX1—Crohn's disease	3.26e-05	0.000269	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TAB1—Crohn's disease	3.25e-05	0.000268	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	3.24e-05	0.000268	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2RA—Crohn's disease	3.2e-05	0.000264	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NOD2—Crohn's disease	3.19e-05	0.000263	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RIPK2—Crohn's disease	3.18e-05	0.000263	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCR6—Crohn's disease	3.17e-05	0.000262	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTGER4—Crohn's disease	3.17e-05	0.000262	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2RA—Crohn's disease	3.11e-05	0.000256	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL3—Crohn's disease	3.1e-05	0.000256	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RBX1—Crohn's disease	3.1e-05	0.000256	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1B—Crohn's disease	3.09e-05	0.000255	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2RA—Crohn's disease	3.05e-05	0.000252	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTGER4—Crohn's disease	3.02e-05	0.000249	CbGpPWpGaD
Amlexanox—FGF1—Immune System—SOCS1—Crohn's disease	3.01e-05	0.000248	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RASGRP1—Crohn's disease	3e-05	0.000248	CbGpPWpGaD
Amlexanox—S100A12—Immune System—TYK2—Crohn's disease	2.96e-05	0.000245	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCR6—Crohn's disease	2.96e-05	0.000244	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—TYK2—Crohn's disease	2.91e-05	0.00024	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RBX1—Crohn's disease	2.87e-05	0.000237	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—UBE2D1—Crohn's disease	2.86e-05	0.000236	CbGpPWpGaD
Amlexanox—S100A12—Immune System—JAK2—Crohn's disease	2.83e-05	0.000233	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2RA—Crohn's disease	2.82e-05	0.000233	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTGER4—Crohn's disease	2.79e-05	0.000231	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IFNG—Crohn's disease	2.77e-05	0.000229	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—JAK2—Crohn's disease	2.77e-05	0.000229	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RIPK2—Crohn's disease	2.77e-05	0.000229	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—JAK2—Crohn's disease	2.72e-05	0.000225	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SOCS1—Crohn's disease	2.72e-05	0.000224	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—UBE2D1—Crohn's disease	2.72e-05	0.000224	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL18—Crohn's disease	2.71e-05	0.000223	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL3—Crohn's disease	2.7e-05	0.000223	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD4—Crohn's disease	2.68e-05	0.000221	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RBX1—Crohn's disease	2.67e-05	0.000221	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RIPK2—Crohn's disease	2.64e-05	0.000218	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD4—Crohn's disease	2.63e-05	0.000217	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RASGRP1—Crohn's disease	2.61e-05	0.000216	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTGER4—Crohn's disease	2.6e-05	0.000215	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TYK2—Crohn's disease	2.59e-05	0.000214	CbGpPWpGaD
Amlexanox—IL3—Immune System—STAT3—Crohn's disease	2.59e-05	0.000214	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL3—Crohn's disease	2.57e-05	0.000212	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD4—Crohn's disease	2.52e-05	0.000208	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—UBE2D1—Crohn's disease	2.52e-05	0.000208	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—Crohn's disease	2.49e-05	0.000206	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—Crohn's disease	2.49e-05	0.000205	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RASGRP1—Crohn's disease	2.49e-05	0.000205	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CXCL8—Crohn's disease	2.49e-05	0.000205	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1B—Crohn's disease	2.47e-05	0.000204	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—JAK2—Crohn's disease	2.47e-05	0.000204	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RIPK2—Crohn's disease	2.44e-05	0.000201	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2RA—Crohn's disease	2.4e-05	0.000198	CbGpPWpGaD
Amlexanox—FGF1—Disease—SMAD3—Crohn's disease	2.4e-05	0.000198	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TYK2—Crohn's disease	2.39e-05	0.000197	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL3—Crohn's disease	2.38e-05	0.000196	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—JAK2—Crohn's disease	2.37e-05	0.000196	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SOCS1—Crohn's disease	2.37e-05	0.000195	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SMAD3—Crohn's disease	2.35e-05	0.000194	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—UBE2D1—Crohn's disease	2.35e-05	0.000194	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RASGRP1—Crohn's disease	2.3e-05	0.00019	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—JAK2—Crohn's disease	2.28e-05	0.000188	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RIPK2—Crohn's disease	2.27e-05	0.000188	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CRP—Crohn's disease	2.27e-05	0.000187	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCL8—Crohn's disease	2.26e-05	0.000186	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TYK2—Crohn's disease	2.26e-05	0.000186	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—JAK2—Crohn's disease	2.26e-05	0.000186	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SOCS1—Crohn's disease	2.25e-05	0.000186	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL3—Crohn's disease	2.22e-05	0.000183	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2RA—Crohn's disease	2.17e-05	0.000179	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TLR4—Crohn's disease	2.17e-05	0.000179	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCL8—Crohn's disease	2.16e-05	0.000179	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—JAK2—Crohn's disease	2.15e-05	0.000178	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TYK2—Crohn's disease	2.15e-05	0.000177	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RASGRP1—Crohn's disease	2.15e-05	0.000177	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—JAK2—Crohn's disease	2.09e-05	0.000172	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SOCS1—Crohn's disease	2.08e-05	0.000172	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ICAM1—Crohn's disease	2.08e-05	0.000172	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCL8—Crohn's disease	2.08e-05	0.000172	CbGpPWpGaD
Amlexanox—S100A12—Immune System—STAT3—Crohn's disease	2.07e-05	0.000171	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCL8—Crohn's disease	2.06e-05	0.00017	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—JAK2—Crohn's disease	2.05e-05	0.000169	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SMAD3—Crohn's disease	2.04e-05	0.000169	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TYK2—Crohn's disease	1.99e-05	0.000164	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—Crohn's disease	1.98e-05	0.000163	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCL8—Crohn's disease	1.96e-05	0.000162	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SMAD3—Crohn's disease	1.94e-05	0.000161	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SOCS1—Crohn's disease	1.94e-05	0.00016	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCL8—Crohn's disease	1.91e-05	0.000157	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—JAK2—Crohn's disease	1.9e-05	0.000156	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2RA—Crohn's disease	1.89e-05	0.000156	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL8—Crohn's disease	1.87e-05	0.000154	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—Crohn's disease	1.81e-05	0.000149	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2RA—Crohn's disease	1.8e-05	0.000149	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SMAD3—Crohn's disease	1.8e-05	0.000149	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL8—Crohn's disease	1.73e-05	0.000143	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TYK2—Crohn's disease	1.69e-05	0.00014	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SMAD3—Crohn's disease	1.68e-05	0.000138	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—STAT3—Crohn's disease	1.67e-05	0.000138	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2RA—Crohn's disease	1.67e-05	0.000138	CbGpPWpGaD
Amlexanox—FGF1—Immune System—JAK2—Crohn's disease	1.62e-05	0.000133	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNG—Crohn's disease	1.59e-05	0.000131	CbGpPWpGaD
Amlexanox—FGF1—Disease—TYK2—Crohn's disease	1.56e-05	0.000129	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2RA—Crohn's disease	1.55e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TYK2—Crohn's disease	1.53e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—Crohn's disease	1.53e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Disease—JAK2—Crohn's disease	1.49e-05	0.000123	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JAK2—Crohn's disease	1.46e-05	0.000121	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—Crohn's disease	1.45e-05	0.00012	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—Crohn's disease	1.42e-05	0.000117	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—Crohn's disease	1.41e-05	0.000117	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—Crohn's disease	1.41e-05	0.000117	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—Crohn's disease	1.4e-05	0.000116	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL8—Crohn's disease	1.33e-05	0.00011	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TYK2—Crohn's disease	1.33e-05	0.00011	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JAK2—Crohn's disease	1.27e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TYK2—Crohn's disease	1.27e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—Crohn's disease	1.27e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JAK2—Crohn's disease	1.21e-05	9.99e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—STAT3—Crohn's disease	1.19e-05	9.79e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TYK2—Crohn's disease	1.17e-05	9.69e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—Crohn's disease	1.17e-05	9.65e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL8—Crohn's disease	1.16e-05	9.58e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JAK2—Crohn's disease	1.12e-05	9.24e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL8—Crohn's disease	1.1e-05	9.12e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—Crohn's disease	1.1e-05	9.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TYK2—Crohn's disease	1.09e-05	9.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—STAT3—Crohn's disease	1.09e-05	9.03e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—STAT3—Crohn's disease	1.07e-05	8.85e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—Crohn's disease	1.05e-05	8.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JAK2—Crohn's disease	1.04e-05	8.62e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL8—Crohn's disease	1.02e-05	8.44e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—Crohn's disease	9.72e-06	8.02e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL8—Crohn's disease	9.53e-06	7.87e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—STAT3—Crohn's disease	9.33e-06	7.7e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—STAT3—Crohn's disease	8.88e-06	7.33e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—Crohn's disease	8.28e-06	6.83e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—STAT3—Crohn's disease	8.22e-06	6.79e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT3—Crohn's disease	7.66e-06	6.33e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—Crohn's disease	7.64e-06	6.31e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—Crohn's disease	7.49e-06	6.18e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—Crohn's disease	6.52e-06	5.38e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—Crohn's disease	6.21e-06	5.12e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—Crohn's disease	5.74e-06	4.74e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—Crohn's disease	5.35e-06	4.42e-05	CbGpPWpGaD
